Last reviewed · How we verify
FIBRIN
At a glance
| Generic name | FIBRIN |
|---|---|
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
Common side effects
- Skin graft failure
- Hematoma/seroma
- Hematoma
- Pruritus
Serious adverse events
- Air embolism
Key clinical trials
- Surgical Treatment of Peri-implantitis With Adjunctive Application of Platelet Rich Fibrin (PRF) (NA)
- High-Purity Type I Collagen Nerve Wrapping in Peripheral Nerve Procedures: A Prospective Registry (NA)
- Clinical Comparison of Alb-PRF vs PRF on Postoperative Morbidity Following FGG Harvesting (NA)
- Comparing Clinical Outcomes of the One-step Cartilage Transplantation in Cartilage Defects of the Knee With Conservative Treatment (PHASE3)
- Evaluation of the Effects of I-PRF and C-PRF on Gingival Phenotype (NA)
- Hyaluronic Acid and Albumin-PRF in Non-Surgical Periodontal Therapy (NA)
- Evaluating The Use of CGF Made Plugs in Mandibular Extraction Sites of Lower Impacted 3rd Molars. (NA)
- Evaluation of the Modified VISTA Technique Using ALB-PRF vs CTG in the Treatment of Multiple Miller Class III Recessions (PHASE2,PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FIBRIN CI brief — competitive landscape report
- FIBRIN updates RSS · CI watch RSS